Effects of combined inhibition of ATP-sensitive potassium channels, nitric oxide, and prostaglandins on hyperemia during moderate exercise

1 Department of Anesthesiology and 2 General Clinical Research Center, Mayo Clinic, Rochester, Minnesota Submitted 30 December 2005 ; accepted in final form 6 February 2006 ATP-sensitive potassium (K ATP ) channels have been suggested to contribute to coronary and skeletal muscle vasodilation during...

Full description

Saved in:
Bibliographic Details
Published inJournal of applied physiology (1985) Vol. 100; no. 5; pp. 1506 - 1512
Main Authors Schrage, William G, Dietz, Niki M, Joyner, Michael J
Format Journal Article
LanguageEnglish
Published Bethesda, MD Am Physiological Soc 01.05.2006
American Physiological Society
Subjects
Online AccessGet full text
ISSN8750-7587
1522-1601
DOI10.1152/japplphysiol.01639.2005

Cover

Loading…
Abstract 1 Department of Anesthesiology and 2 General Clinical Research Center, Mayo Clinic, Rochester, Minnesota Submitted 30 December 2005 ; accepted in final form 6 February 2006 ATP-sensitive potassium (K ATP ) channels have been suggested to contribute to coronary and skeletal muscle vasodilation during exercise, either alone or interacting in a parallel or redundant process with nitric oxide (NO), prostaglandins (PGs), and adenosine. We tested the hypothesis that K ATP channels, alone or in combination with NO and PGs, regulate exercise hyperemia in forearm muscle. Eighteen healthy young adults performed 20 min of moderate dynamic forearm exercise, with forearm blood flow (FBF) measured via Doppler ultrasound. After steady-state FBF was achieved for 5 min (saline control), the K ATP inhibitor glibenclamide (Glib) was infused into the brachial artery for 5 min (10 µg·dl –1 ·min –1 ), followed by saline infusion during the final 10 min of exercise ( n = 9). Exercise increased FBF from 71 ± 11 to 239 ± 24 ml/min, and FBF was not altered by 5 min of Glib. Systemic plasma Glib levels were above the therapeutic range, and Glib increased insulin levels by 50%, whereas blood glucose was unchanged (88 ± 2 vs. 90 ± 2 mg/dl). In nine additional subjects, Glib was followed by combined infusion of N G -nitro- L -arginine methyl ester ( L -NAME) plus ketorolac (to inhibit NO and PGs, respectively). As above, Glib had no effect on FBF but addition of L -NAME + ketorolac (i.e., triple blockade) reduced FBF by 15% below steady-state exercise levels in seven of nine subjects. Interestingly, triple blockade in two subjects caused FBF to transiently and dramatically decrease. This was followed by an acute recovery of flow above steady-state exercise values. We conclude 1 ) opening of K ATP channels is not obligatory for forearm exercise hyperemia, and 2 ) triple blockade of NO, PGs, and K ATP channels does not reduce hyperemia more than the inhibition of NO and PGs in most subjects. However, some subjects are sensitive to triple blockade, but they are able to restore FBF acutely during exercise. Future studies are required to determine the nature of these compensatory mechanisms in the affected individuals. Doppler ultrasound; N G -nitro- L -arginine methyl ester; blood flow; human; potassium; nitric oxide synthase; cyclooxygenase Address for reprint requests and other correspondence: W. G. Schrage, Dept. of Anesthesiology, Joseph 4-184W, Mayo Clinic, Rochester, MN 55905 (e-mail: schrage.william{at}mayo.edu )
AbstractList ATP-sensitive potassium (KATP) channels have been suggested to contribute to coronary and skeletal muscle vasodilation during exercise, either alone or interacting in a parallel or redundant process with nitric oxide (NO), prostaglandins (PGs), and adenosine. We tested the hypothesis that KATP channels, alone or in combination with NO and PGs, regulate exercise hyperemia in forearm muscle. Eighteen healthy young adults performed 20 min of moderate dynamic forearm exercise, with forearm blood flow (FBF) measured via Doppler ultrasound. After steady-state FBF was achieved for 5 min (saline control), the KATP inhibitor glibenclamide (Glib) was infused into the brachial artery for 5 min (10 microg(symbol)dl-1(symbol)min-1), followed by saline infusion during the final 10 min of exercise (n = 9). Exercise increased FBF from 71 +/- 11 to 239 +/- 24 ml/min, and FBF was not altered by 5 min of Glib. Systemic plasma Glib levels were above the therapeutic range, and Glib increased insulin levels by approximately 50%, whereas blood glucose was unchanged (88 +/- 2 vs. 90 +/- 2 mg/dl). In nine additional subjects, Glib was followed by combined infusion of NG-nitro-L-arginine methyl ester (L-NAME) plus ketorolac (to inhibit NO and PGs, respectively). As above, Glib had no effect on FBF but addition of L-NAME + ketorolac (i.e., triple blockade) reduced FBF by approximately 15% below steady-state exercise levels in seven of nine subjects. Interestingly, triple blockade in two subjects caused FBF to transiently and dramatically decrease. This was followed by an acute recovery of flow above steady-state exercise values. We conclude 1) opening of KATP channels is not obligatory for forearm exercise hyperemia, and 2) triple blockade of NO, PGs, and KATP channels does not reduce hyperemia more than the inhibition of NO and PGs in most subjects. However, some subjects are sensitive to triple blockade, but they are able to restore FBF acutely during exercise. Future studies are required to determine the nature of these compensatory mechanisms in the affected individuals.[PUBLICATION ABSTRACT]
ATP-sensitive potassium (K ATP ) channels have been suggested to contribute to coronary and skeletal muscle vasodilation during exercise, either alone or interacting in a parallel or redundant process with nitric oxide (NO), prostaglandins (PGs), and adenosine. We tested the hypothesis that K ATP channels, alone or in combination with NO and PGs, regulate exercise hyperemia in forearm muscle. Eighteen healthy young adults performed 20 min of moderate dynamic forearm exercise, with forearm blood flow (FBF) measured via Doppler ultrasound. After steady-state FBF was achieved for 5 min (saline control), the K ATP inhibitor glibenclamide (Glib) was infused into the brachial artery for 5 min (10 μg·dl −1 ·min −1 ), followed by saline infusion during the final 10 min of exercise ( n = 9). Exercise increased FBF from 71 ± 11 to 239 ± 24 ml/min, and FBF was not altered by 5 min of Glib. Systemic plasma Glib levels were above the therapeutic range, and Glib increased insulin levels by ∼50%, whereas blood glucose was unchanged (88 ± 2 vs. 90 ± 2 mg/dl). In nine additional subjects, Glib was followed by combined infusion of N G -nitro-l-arginine methyl ester (l-NAME) plus ketorolac (to inhibit NO and PGs, respectively). As above, Glib had no effect on FBF but addition of l-NAME + ketorolac (i.e., triple blockade) reduced FBF by ∼15% below steady-state exercise levels in seven of nine subjects. Interestingly, triple blockade in two subjects caused FBF to transiently and dramatically decrease. This was followed by an acute recovery of flow above steady-state exercise values. We conclude 1) opening of K ATP channels is not obligatory for forearm exercise hyperemia, and 2) triple blockade of NO, PGs, and K ATP channels does not reduce hyperemia more than the inhibition of NO and PGs in most subjects. However, some subjects are sensitive to triple blockade, but they are able to restore FBF acutely during exercise. Future studies are required to determine the nature of these compensatory mechanisms in the affected individuals.
1 Department of Anesthesiology and 2 General Clinical Research Center, Mayo Clinic, Rochester, Minnesota Submitted 30 December 2005 ; accepted in final form 6 February 2006 ATP-sensitive potassium (K ATP ) channels have been suggested to contribute to coronary and skeletal muscle vasodilation during exercise, either alone or interacting in a parallel or redundant process with nitric oxide (NO), prostaglandins (PGs), and adenosine. We tested the hypothesis that K ATP channels, alone or in combination with NO and PGs, regulate exercise hyperemia in forearm muscle. Eighteen healthy young adults performed 20 min of moderate dynamic forearm exercise, with forearm blood flow (FBF) measured via Doppler ultrasound. After steady-state FBF was achieved for 5 min (saline control), the K ATP inhibitor glibenclamide (Glib) was infused into the brachial artery for 5 min (10 µg·dl –1 ·min –1 ), followed by saline infusion during the final 10 min of exercise ( n = 9). Exercise increased FBF from 71 ± 11 to 239 ± 24 ml/min, and FBF was not altered by 5 min of Glib. Systemic plasma Glib levels were above the therapeutic range, and Glib increased insulin levels by 50%, whereas blood glucose was unchanged (88 ± 2 vs. 90 ± 2 mg/dl). In nine additional subjects, Glib was followed by combined infusion of N G -nitro- L -arginine methyl ester ( L -NAME) plus ketorolac (to inhibit NO and PGs, respectively). As above, Glib had no effect on FBF but addition of L -NAME + ketorolac (i.e., triple blockade) reduced FBF by 15% below steady-state exercise levels in seven of nine subjects. Interestingly, triple blockade in two subjects caused FBF to transiently and dramatically decrease. This was followed by an acute recovery of flow above steady-state exercise values. We conclude 1 ) opening of K ATP channels is not obligatory for forearm exercise hyperemia, and 2 ) triple blockade of NO, PGs, and K ATP channels does not reduce hyperemia more than the inhibition of NO and PGs in most subjects. However, some subjects are sensitive to triple blockade, but they are able to restore FBF acutely during exercise. Future studies are required to determine the nature of these compensatory mechanisms in the affected individuals. Doppler ultrasound; N G -nitro- L -arginine methyl ester; blood flow; human; potassium; nitric oxide synthase; cyclooxygenase Address for reprint requests and other correspondence: W. G. Schrage, Dept. of Anesthesiology, Joseph 4-184W, Mayo Clinic, Rochester, MN 55905 (e-mail: schrage.william{at}mayo.edu )
ATP-sensitive potassium (KATP) channels have been suggested to contribute to coronary and skeletal muscle vasodilation during exercise, either alone or interacting in a parallel or redundant process with nitric oxide (NO), prostaglandins (PGs), and adenosine. We tested the hypothesis that KATP channels, alone or in combination with NO and PGs, regulate exercise hyperemia in forearm muscle. Eighteen healthy young adults performed 20 min of moderate dynamic forearm exercise, with forearm blood flow (FBF) measured via Doppler ultrasound. After steady-state FBF was achieved for 5 min (saline control), the KATP inhibitor glibenclamide (Glib) was infused into the brachial artery for 5 min (10 microg.dl(-1).min(-1)), followed by saline infusion during the final 10 min of exercise (n = 9). Exercise increased FBF from 71 +/- 11 to 239 +/- 24 ml/min, and FBF was not altered by 5 min of Glib. Systemic plasma Glib levels were above the therapeutic range, and Glib increased insulin levels by approximately 50%, whereas blood glucose was unchanged (88 +/- 2 vs. 90 +/- 2 mg/dl). In nine additional subjects, Glib was followed by combined infusion of NG-nitro-L-arginine methyl ester (L-NAME) plus ketorolac (to inhibit NO and PGs, respectively). As above, Glib had no effect on FBF but addition of L-NAME + ketorolac (i.e., triple blockade) reduced FBF by approximately 15% below steady-state exercise levels in seven of nine subjects. Interestingly, triple blockade in two subjects caused FBF to transiently and dramatically decrease. This was followed by an acute recovery of flow above steady-state exercise values. We conclude 1) opening of KATP channels is not obligatory for forearm exercise hyperemia, and 2) triple blockade of NO, PGs, and KATP channels does not reduce hyperemia more than the inhibition of NO and PGs in most subjects. However, some subjects are sensitive to triple blockade, but they are able to restore FBF acutely during exercise. Future studies are required to determine the nature of these compensatory mechanisms in the affected individuals.
ATP-sensitive potassium (KATP) channels have been suggested to contribute to coronary and skeletal muscle vasodilation during exercise, either alone or interacting in a parallel or redundant process with nitric oxide (NO), prostaglandins (PGs), and adenosine. We tested the hypothesis that KATP channels, alone or in combination with NO and PGs, regulate exercise hyperemia in forearm muscle. Eighteen healthy young adults performed 20 min of moderate dynamic forearm exercise, with forearm blood flow (FBF) measured via Doppler ultrasound. After steady-state FBF was achieved for 5 min (saline control), the KATP inhibitor glibenclamide (Glib) was infused into the brachial artery for 5 min (10 microg.dl(-1).min(-1)), followed by saline infusion during the final 10 min of exercise (n = 9). Exercise increased FBF from 71 +/- 11 to 239 +/- 24 ml/min, and FBF was not altered by 5 min of Glib. Systemic plasma Glib levels were above the therapeutic range, and Glib increased insulin levels by approximately 50%, whereas blood glucose was unchanged (88 +/- 2 vs. 90 +/- 2 mg/dl). In nine additional subjects, Glib was followed by combined infusion of NG-nitro-L-arginine methyl ester (L-NAME) plus ketorolac (to inhibit NO and PGs, respectively). As above, Glib had no effect on FBF but addition of L-NAME + ketorolac (i.e., triple blockade) reduced FBF by approximately 15% below steady-state exercise levels in seven of nine subjects. Interestingly, triple blockade in two subjects caused FBF to transiently and dramatically decrease. This was followed by an acute recovery of flow above steady-state exercise values. We conclude 1) opening of KATP channels is not obligatory for forearm exercise hyperemia, and 2) triple blockade of NO, PGs, and KATP channels does not reduce hyperemia more than the inhibition of NO and PGs in most subjects. However, some subjects are sensitive to triple blockade, but they are able to restore FBF acutely during exercise. Future studies are required to determine the nature of these compensatory mechanisms in the affected individuals.ATP-sensitive potassium (KATP) channels have been suggested to contribute to coronary and skeletal muscle vasodilation during exercise, either alone or interacting in a parallel or redundant process with nitric oxide (NO), prostaglandins (PGs), and adenosine. We tested the hypothesis that KATP channels, alone or in combination with NO and PGs, regulate exercise hyperemia in forearm muscle. Eighteen healthy young adults performed 20 min of moderate dynamic forearm exercise, with forearm blood flow (FBF) measured via Doppler ultrasound. After steady-state FBF was achieved for 5 min (saline control), the KATP inhibitor glibenclamide (Glib) was infused into the brachial artery for 5 min (10 microg.dl(-1).min(-1)), followed by saline infusion during the final 10 min of exercise (n = 9). Exercise increased FBF from 71 +/- 11 to 239 +/- 24 ml/min, and FBF was not altered by 5 min of Glib. Systemic plasma Glib levels were above the therapeutic range, and Glib increased insulin levels by approximately 50%, whereas blood glucose was unchanged (88 +/- 2 vs. 90 +/- 2 mg/dl). In nine additional subjects, Glib was followed by combined infusion of NG-nitro-L-arginine methyl ester (L-NAME) plus ketorolac (to inhibit NO and PGs, respectively). As above, Glib had no effect on FBF but addition of L-NAME + ketorolac (i.e., triple blockade) reduced FBF by approximately 15% below steady-state exercise levels in seven of nine subjects. Interestingly, triple blockade in two subjects caused FBF to transiently and dramatically decrease. This was followed by an acute recovery of flow above steady-state exercise values. We conclude 1) opening of KATP channels is not obligatory for forearm exercise hyperemia, and 2) triple blockade of NO, PGs, and KATP channels does not reduce hyperemia more than the inhibition of NO and PGs in most subjects. However, some subjects are sensitive to triple blockade, but they are able to restore FBF acutely during exercise. Future studies are required to determine the nature of these compensatory mechanisms in the affected individuals.
ATP-sensitive potassium (K sub(ATP)) channels have been suggested to contribute to coronary and skeletal muscle vasodilation during exercise, either alone or interacting in a parallel or redundant process with nitric oxide (NO), prostaglandins (PGs), and adenosine. We tested the hypothesis that K sub(ATP) channels, alone or in combination with NO and PGs, regulate exercise hyperemia in forearm muscle. Eighteen healthy young adults performed 20 min of moderate dynamic forearm exercise, with forearm blood flow (FBF) measured via Doppler ultrasound. After steady-state FBF was achieved for 5 min (saline control), the K sub(ATP) inhibitor glibenclamide (Glib) was infused into the brachial artery for 5 min (10 mu g.dl super(-1).min super(-1)), followed by saline infusion during the final 10 min of exercise (n = 9). Exercise increased FBF from 71 plus or minus 11 to 239 plus or minus 24 ml/min, and FBF was not altered by 5 min of Glib. Systemic plasma Glib levels were above the therapeutic range, and Glib increased insulin levels by similar to 50%, whereas blood glucose was unchanged (88 plus or minus 2 vs. 90 plus or minus 2 mg/dl). In nine additional subjects, Glib was followed by combined infusion of N super(G)-nitro-L-arginine methyl ester (L-NAME) plus ketorolac (to inhibit NO and PGs, respectively). As above, Glib had no effect on FBF but addition of L-NAME + ketorolac (i.e., triple blockade) reduced FBF by similar to 15% below steady-state exercise levels in seven of nine subjects. Interestingly, triple blockade in two subjects caused FBF to transiently and dramatically decrease. This was followed by an acute recovery of flow above steady-state exercise values. We conclude 1) opening of K sub(ATP) channels is not obligatory for forearm exercise hyperemia, and 2) triple blockade of NO, PGs, and K sub(ATP) channels does not reduce hyperemia more than the inhibition of NO and PGs in most subjects. However, some subjects are sensitive to triple blockade, but they are able to restore FBF acutely during exercise. Future studies are required to determine the nature of these compensatory mechanisms in the affected individuals.
Author Dietz, Niki M
Schrage, William G
Joyner, Michael J
Author_xml – sequence: 1
  fullname: Schrage, William G
– sequence: 2
  fullname: Dietz, Niki M
– sequence: 3
  fullname: Joyner, Michael J
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17729607$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/16469932$$D View this record in MEDLINE/PubMed
BookMark eNqFkt9u0zAUxi00xLrBK4CFBBLSWuwkjuMLLqZpA6RJcFGuLcc5blwldrCT0b4CT41DC0OT0K5sHf--4_PnO0MnzjtA6BUlK0pZ9n6rhqEb2n20vlsRWuZilRHCnqBFes2WtCT0BC0qzsiSs4qforMYt4TQomD0GTqlZVEKkWcL9PPaGNBjxN5g7fvaOmiwda2t7Wi9m8OX66_LCC6mwB3gwY8qRjv1WLfKOejiBXZ2DFZjv7MNXGDlGjwEH0e16dLdupTc4XY_QIDeKtxMwboN7n0DQY2AYQdB2wjP0VOjuggvjuc5-nZzvb76tLz98vHz1eXtUhdcjEugwKDmOlfEiIrp1HBlaGqH8yI3rCh0VTElRK3ynPI8q-umFDUxvGkqXqomP0dvD3lTkd8niKPsbdTQpWLBT1GWvCpzltNHQcopI5UgCXz9ANz6KbjUhMyyjApaiDnbyyM01T00cgi2V2Ev_-wiAW-OgIpadSYol8Zyz3GeiZLwxH04cDoNOQYwUttRzdsag7KdpETOHpH_ekT-9oicPZL0_IH-7xePKt8dlK3dtD9sAHmE_GY_i1ICIplMUykTy_7P3kxdt4bdOIvuNXJoTP4LUSXpJQ
CODEN JAPHEV
CitedBy_id crossref_primary_10_1177_1358863X14565374
crossref_primary_10_1097_01_mco_0000247473_49284_e3
crossref_primary_10_53520_jen2022_103114
crossref_primary_10_1096_fj_10_158956
crossref_primary_10_1016_j_resp_2015_11_012
crossref_primary_10_1152_ajpheart_00772_2014
crossref_primary_10_1258_ebm_2009_009201
crossref_primary_10_1152_physrev_00035_2013
crossref_primary_10_1007_s00421_011_2035_8
crossref_primary_10_1080_10739680701282887
crossref_primary_10_1152_japplphysiol_00073_2014
crossref_primary_10_1007_s00421_022_04901_x
crossref_primary_10_3390_ijms24097927
crossref_primary_10_1152_japplphysiol_00726_2020
crossref_primary_10_1111_bcp_13804
crossref_primary_10_1152_ajpheart_00649_2019
crossref_primary_10_1113_JP275913
crossref_primary_10_1152_ajpheart_00212_2014
crossref_primary_10_1249_MSS_0b013e3181909d9d
crossref_primary_10_1590_S0100_879X2011007500043
crossref_primary_10_1152_japplphysiol_01016_2007
crossref_primary_10_1007_s00421_012_2570_y
crossref_primary_10_1007_s00421_014_2932_8
crossref_primary_10_1016_j_resp_2017_01_009
Cites_doi 10.1152/ajpheart.00916.2002
10.1172/JCI117653
10.1152/ajpheart.1996.270.5.H1649
10.1152/ajpheart.1997.273.5.H2388
10.1161/01.RES.82.3.346
10.1152/ajpregu.00303.2002
10.1113/jphysiol.2002.037937
10.1152/ajpheart.2001.280.1.H22
10.1080/10739680590896072
10.1152/ajpheart.1996.271.4.H1594
10.1007/s001250050615
10.1172/JCI119448
10.1113/jphysiol.2003.049940
10.1152/ajpheart.00315.2002
10.1161/01.CIR.88.3.1245
10.1042/cs1040039
10.2307/2531734
10.1023/A:1007835003493
10.1111/j.1469-7793.2001.0257j.x
10.1161/01.HYP.32.4.740
10.1172/JCI118524
10.1152/ajpheart.2001.280.2.H868
10.1055/s-2007-979843
10.1113/jphysiol.2004.061283
10.1161/01.HYP.37.2.599
ContentType Journal Article
Copyright 2006 INIST-CNRS
Copyright American Physiological Society May 2006
Copyright_xml – notice: 2006 INIST-CNRS
– notice: Copyright American Physiological Society May 2006
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7TK
7TS
7U7
8FD
C1K
FR3
P64
7X8
DOI 10.1152/japplphysiol.01639.2005
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Neurosciences Abstracts
Physical Education Index
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Technology Research Database
Toxicology Abstracts
Chemoreception Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Physical Education Index
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Technology Research Database
CrossRef

MEDLINE
MEDLINE - Academic
Physical Education Index
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1522-1601
EndPage 1512
ExternalDocumentID 1033695531
16469932
17729607
10_1152_japplphysiol_01639_2005
jap_100_5_1506
Genre Journal Article
Research Support, N.I.H., Extramural
Feature
GrantInformation_xml – fundername: NCRR NIH HHS
  grantid: RR-00585
– fundername: NHLBI NIH HHS
  grantid: HL-69692
– fundername: NHLBI NIH HHS
  grantid: HL-46493
GroupedDBID -
02
2WC
39C
3O-
4.4
53G
55
5VS
85S
AALRV
ABFLS
ABOCM
ABUFD
ACGFS
ACIWK
ACPRK
ADBBV
ADBIT
AEILP
AENEX
AEULQ
AFDAS
AFRAH
AGCDD
ALMA_UNASSIGNED_HOLDINGS
BAWUL
C1A
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GJ
GX1
H13
H~9
KQ8
L7B
MYA
NEJ
O0-
OHT
OK1
P-O
P2P
PQEST
PQQKQ
RAP
RHF
RHI
RPL
SJN
UHB
UKR
UPT
WH7
WOQ
X
X7M
YCJ
---
-~X
.55
.GJ
18M
1CY
29J
8M5
AAFWJ
AAYXX
ABCQX
ABDNZ
ABHWK
ABJNI
ABKWE
ACBEA
ACGFO
ACKIV
ACYGS
ADFNX
ADXHL
AETEA
AFOSN
AGNAY
AI.
AIDAL
AJUXI
BKKCC
BTFSW
C2-
CITATION
EMOBN
ITBOX
J5H
MVM
P6G
RPRKH
TR2
VH1
W8F
XOL
XSW
YBH
YQJ
YQT
YWH
ZXP
~02
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
VXZ
7QP
7QR
7TK
7TS
7U7
8FD
C1K
FR3
P64
7X8
ID FETCH-LOGICAL-c479t-e1e5eb7c3a0f985c1528f16997743f544c885a99ba331732bbd69b0f7dd876ad3
ISSN 8750-7587
IngestDate Fri Jul 11 04:27:45 EDT 2025
Fri Jul 11 02:03:38 EDT 2025
Mon Jun 30 08:30:33 EDT 2025
Wed Feb 19 01:43:57 EST 2025
Mon Jul 21 09:16:38 EDT 2025
Thu Apr 24 23:02:07 EDT 2025
Tue Jul 01 01:13:16 EDT 2025
Mon May 06 11:50:05 EDT 2019
Tue Jan 05 17:53:17 EST 2021
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Physical exercise
Prostaglandin-endoperoxide synthase
NG-nitro-L-arginine methyl ester
Ionic channel
Inorganic element
Doppler ultrasound
Arginine
Eicosanoid
Inhibition
nitric oxide synthase
Ultrasound
Human
Prostaglandin
Enzyme
Arachidonic acid derivatives
cyclooxygenase
Nitric-oxide synthase
Blood flow
Vertebrata
Mammalia
Aminoacid
Nitric oxide
Hemodynamics
Oxidoreductases
ATP
Potassium
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c479t-e1e5eb7c3a0f985c1528f16997743f544c885a99ba331732bbd69b0f7dd876ad3
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
PMID 16469932
PQID 222191491
PQPubID 40905
PageCount 7
ParticipantIDs proquest_miscellaneous_67863531
highwire_physiology_jap_100_5_1506
proquest_journals_222191491
proquest_miscellaneous_17150890
pascalfrancis_primary_17729607
crossref_primary_10_1152_japplphysiol_01639_2005
pubmed_primary_16469932
crossref_citationtrail_10_1152_japplphysiol_01639_2005
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2006-05-01
PublicationDateYYYYMMDD 2006-05-01
PublicationDate_xml – month: 05
  year: 2006
  text: 2006-05-01
  day: 01
PublicationDecade 2000
PublicationPlace Bethesda, MD
PublicationPlace_xml – name: Bethesda, MD
– name: United States
– name: Bethesda
PublicationTitle Journal of applied physiology (1985)
PublicationTitleAlternate J Appl Physiol (1985)
PublicationYear 2006
Publisher Am Physiological Soc
American Physiological Society
Publisher_xml – name: Am Physiological Soc
– name: American Physiological Society
References R21
R20
R23
R22
R25
R24
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R12
R11
R14
R13
R16
R15
R18
R17
R19
References_xml – ident: R17
  doi: 10.1152/ajpheart.00916.2002
– ident: R10
  doi: 10.1172/JCI117653
– ident: R20
  doi: 10.1152/ajpheart.1996.270.5.H1649
– ident: R22
  doi: 10.1152/ajpheart.1997.273.5.H2388
– ident: R15
  doi: 10.1161/01.RES.82.3.346
– ident: R18
  doi: 10.1152/ajpregu.00303.2002
– ident: R19
  doi: 10.1113/jphysiol.2002.037937
– ident: R7
  doi: 10.1152/ajpheart.2001.280.1.H22
– ident: R16
  doi: 10.1080/10739680590896072
– ident: R1
  doi: 10.1152/ajpheart.1996.271.4.H1594
– ident: R3
  doi: 10.1007/s001250050615
– ident: R23
  doi: 10.1172/JCI119448
– ident: R6
  doi: 10.1113/jphysiol.2003.049940
– ident: R12
  doi: 10.1152/ajpheart.00315.2002
– ident: R8
  doi: 10.1161/01.CIR.88.3.1245
– ident: R11
  doi: 10.1042/cs1040039
– ident: R25
  doi: 10.2307/2531734
– ident: R2
  doi: 10.1023/A:1007835003493
– ident: R13
  doi: 10.1111/j.1469-7793.2001.0257j.x
– ident: R5
  doi: 10.1161/01.HYP.32.4.740
– ident: R9
  doi: 10.1172/JCI118524
– ident: R24
  doi: 10.1152/ajpheart.2001.280.2.H868
– ident: R4
  doi: 10.1055/s-2007-979843
– ident: R21
  doi: 10.1113/jphysiol.2004.061283
– ident: R14
  doi: 10.1161/01.HYP.37.2.599
SSID ssj0014451
Score 1.9510198
Snippet 1 Department of Anesthesiology and 2 General Clinical Research Center, Mayo Clinic, Rochester, Minnesota Submitted 30 December 2005 ; accepted in final form 6...
ATP-sensitive potassium (K ATP ) channels have been suggested to contribute to coronary and skeletal muscle vasodilation during exercise, either alone or...
ATP-sensitive potassium (KATP) channels have been suggested to contribute to coronary and skeletal muscle vasodilation during exercise, either alone or...
ATP-sensitive potassium (K sub(ATP)) channels have been suggested to contribute to coronary and skeletal muscle vasodilation during exercise, either alone or...
SourceID proquest
pubmed
pascalfrancis
crossref
highwire
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1506
SubjectTerms Adenosine
Adenosine Triphosphate - physiology
Adult
ATP
Biological and medical sciences
Enzyme Inhibitors - pharmacology
Exercise
Exercise - physiology
Female
Forearm - blood supply
Forearm - physiology
Fundamental and applied biological sciences. Psychology
Glyburide - pharmacology
Human subjects
Humans
Hyperemia - physiopathology
Inhibitor drugs
Ketorolac - pharmacology
Male
Muscle, Skeletal - blood supply
Muscle, Skeletal - physiopathology
NG-Nitroarginine Methyl Ester - pharmacology
Nitric oxide
Nitric Oxide - antagonists & inhibitors
Nitric Oxide - physiology
Potassium
Potassium Channels - drug effects
Potassium Channels - physiology
Prostaglandins - physiology
Regional Blood Flow - drug effects
Regional Blood Flow - physiology
Ultrasonic imaging
Vasodilation - drug effects
Vasodilation - physiology
Young adults
Title Effects of combined inhibition of ATP-sensitive potassium channels, nitric oxide, and prostaglandins on hyperemia during moderate exercise
URI http://jap.physiology.org/cgi/content/abstract/100/5/1506
https://www.ncbi.nlm.nih.gov/pubmed/16469932
https://www.proquest.com/docview/222191491
https://www.proquest.com/docview/17150890
https://www.proquest.com/docview/67863531
Volume 100
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1tb9MwELbKkBBfEGy8hMGwEOLTMtIkzsvHCoamoSHQOmnfIsdx1Gg0qdpUovwE_in_gjvbeUOtGHyJqrS-Or4n9p199xwhb7D2jWB5Zgvm5LYfiNzmTuzaMgQfiGdR7jmYnHzxOTi78s-v2fVo9KsXtbSu0xPxY2teyf9oFe6BXjFL9h802wqFG_AZ9AtX0DBcb6Xj0y4YA8SDjyuRSWlWpEVjB06mX-wVxqirCKFFVYOtXKznKt-3hGURRxheagynr74XmoJXUwdUYDaq-h4YQwPCZuCwLuW84E1mI9bQQZ6JtmrTDjuXGztX7aFoxickh4oj1tuFuBSzJddV3s0OUFf060MhVdFZQO1N0e3enlcbk6xjQv_NCVdvC4MNwkHmqtBP0c72l9UwBNSxwavRy7I00zS40OPAyGjmccfpAZb1ZmVkUdy-XDBXlSmAgTCDcAImsE5gYv0WoPfFXKEI-djApnO79bOJGfhjWW2DHUE8MkMnLMF-3CF3XfBosNjGp6_dgRfyxOmtaP2wJhQROvhuR_eQ7tb0ZWhTNTzXGObLVzCeuS7RstuHUrbU9CF5YMBBJxrRj8hIlvvkYFLyuppv6Fva6mmzT-5dmOiPA_LT4J1WOW3wTju84-0B3mmLd9rg_ZhqtFOF9mMK-KZDrFMQ1GKdaqzTBuu0wfpjcvXxdPr-zDa1RGzhh3Fty7FkMg2Fx50cAC5gYKN8DKMH7o-XM98XUcR4HKfcA4vac9M0C-LUycMsA3uBZ94TsldWpXyGLAcixOy2GET4UnDOGc-EkCHoMI88zyJBo41EGKJ9rPfyLVEON3OTvkYTpVGsBsss4rQNF5pr5u9NThp1J91rnOD21RRQiM066CWLLLfI620Nhhi1yNEAOV1v0BcPnNAihw2UEjMfrhLwNJAsMh5b5FX7LSxWeALJS1mtV9Aey0_Ezu5fgO0MLpAHMp5qhHb_bcD-_DZPcEjudxPNC7JXL9fyJXgPdXqk3rvfFhYiGA
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+combined+inhibition+of+ATP-sensitive+potassium+channels%2C+nitric+oxide%2C+and+prostaglandins+on+hyperemia+during+moderate+exercise&rft.jtitle=Journal+of+applied+physiology+%281985%29&rft.au=Schrage%2C+William+G&rft.au=Dietz%2C+Niki+M&rft.au=Joyner%2C+Michael+J&rft.date=2006-05-01&rft.pub=Am+Physiological+Soc&rft.issn=8750-7587&rft.eissn=1522-1601&rft.volume=100&rft.issue=5&rft.spage=1506&rft_id=info:doi/10.1152%2Fjapplphysiol.01639.2005&rft_id=info%3Apmid%2F16469932&rft.externalDBID=n%2Fa&rft.externalDocID=jap_100_5_1506
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=8750-7587&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=8750-7587&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=8750-7587&client=summon